COL18A1 and melanoma: To investigate its feasibility, we synthesized an HLA-A2-restricted neoantigen in COL18A1, that is, neoantigen peptide (VLLGVKLFGV) and its normal counterpart (VLLGVKLSGV), from a person with melanoma (Fig. 6a)51.